top of page
Dr. Richard Matulewicz on the BackTable Urology Podcast

Dr. Richard Matulewicz

Urologic Oncologist

4 Podcasts • 1 Course on BackTable

Dr. Richard Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York City.

Learn from the experiences and expertise of Dr. Richard Matulewicz and other leading voices in your specialty on the BackTable app.

Clinical Approaches to Testicular Cancer Management
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 327  •  01 Sept 2026

Clinical Approaches to Testicular Cancer Management

What are the key considerations for choosing between surveillance, surgery, and chemotherapy in testicular cancer? On this episode of BackTable Urology, host Dr. Rich Matulewicz is joined by Dr. Sean Kern and Dr. Sam Funt for an in-depth discussion on clinical approaches to testicular cancer. They start with a real-world case, reviewing initial evaluation, imaging, tumor markers, and counseling on fertility, body image, and hypogonadism. The conversation highlights how nuanced patient selection influences decisions between surveillance, surgical intervention, and adjuvant chemotherapy.

More from Dr. Richard Matulewicz

Loading recent podcasts…

GU Tumor Board Cases

Urology Course

2.5 hours, 11 lessons

About

Dr. Richard Matulewicz is a Memorial Sloan Kettering Cancer Center fellowship-trained urologic oncologist and health services researcher with expertise in the open, robotic, and endoscopic surgical treatment of urologic cancers (testicular, kidney, bladder, and prostate). He received his medical degree from Tufts University School of Medicine. Dr. Matulewicz completed his residency at Northwestern followed by two fellowships in New York City. He has a particular interest in improving the way physicians diagnose and treat people with testicular cancer (germ cell tumors). He aims to accomplish this by rigorously studying the impact that various treatment strategies have on health-related quality of life, assessing new ways to integrate novel diagnostics such a micro-RNA into clinical practice, and understanding long-term outcomes of surgical treatments like retroperitoneal lymph node dissection (RPLND).

Visit Memorial Sloan Kettering Cancer Center to learn more about Dr. Richard Matulewicz.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page